摘 要 目的：观察柳氮磺吡啶等药物结合八段锦等康复运动治疗AS的临床疗

摘要目的：观察柳氮磺吡啶等药物结合八段锦等康复运动治疗AS的临床疗效，为AS患者疾病的缓解和治疗提供一定的依据。方法：将40例AS患者随机分为治疗组和对照组，每组20例。治疗组在口服柳氮磺吡啶的基础上结合康复运动进行治疗，对照组采用口服柳氮磺吡啶进行治疗。分别详细记录每位患者治疗前后VAS、BASFI和BASMI评分结果。结果：两组患者在接受治疗后的VAS、 BASMI和BASFI评分均显着降低（P＜0.01），其中两组治疗后VAS差异无统计学意义（P＞0.05），而BASDAI 和BASMI治疗组较对照组改善更为明显（P＜0.05, P＜0.01）。结论：对AS患者来说，柳氮磺吡啶等药物配合康复运动治疗AS比一般治疗更加有效，值得临床推广应用。

摘 要 目的：观察柳氮磺吡啶等药物结合八段锦等康复运动治疗AS的临床疗效，为AS患者疾病的缓解和治疗提供一定的依据。 方法：将40例AS患者随机分为治疗组和对照组，每组20例。 治疗组在口服柳氮磺吡啶的基础上结合康复运动进行治疗，对照组采用口服柳氮磺吡啶进行治疗。 分别详细记录每位患者治疗前后VAS、BASFI和BASMI评分结果。 结果：两组患者在接受治疗后的VAS、 BASMI和BASFI评分均显著降低（P＜0.01），其中两组治疗后VAS差异无统计学意义（P＞0.05），而BASDAI 和 BASMI治疗组较对照组改善更为明显（P＜0.05, P＜0.01）。 结论：对AS患者来说，柳氮磺吡啶等药物配合康复运动治疗AS比一般治疗更加有效，值得临床推广应用。

Objective: To observe the clinical effect of sulfasalazine combined with Baduanjin rehabilitation exercise in the treatment of as, so as to provide some basis for the remission and treatment of as patients. Methods: 40 as patients were randomly divided into treatment group and control group, 20 cases in each group. The treatment group was treated on the basis of oral sulfasalazine combined with rehabilitation exercise, and the control group was treated with oral sulfasalazine. Vas, BASFI and basmi scores of each patient before and after treatment were recorded in detail. Results: the scores of vas, basmi and BASFI in the two groups were significantly reduced (P < 0.01), and there was no significant difference between the two groups (P > 0.05), but the improvement of BASDAI and basmi group was more significant than that of the control group (P < 0.05, P < 0.01). Conclusion: for as patients, sulfasalazine and other drugs combined with rehabilitation exercise are more effective than general treatment, which is worthy of clinical application.<br>